Skip to main content

Meilahti Vaccine Research Center (MeVac)

MeVac is the joint vac­cine research cen­ter of HUS and University of Helsinki where we conduct research commissioned by pharmaceutical companies as well as investigator-initiated studies. We comply with Finnish and EU legislation on medical research, licensing procedures, and good clinical research practices.  

Rokotetutkimuskeskus Mevacin työtekijöitä.

In addition to basically healthy persons, patients from special groups in a university hospital can be examined at our vaccine research center. For some rare diseases or diseases requiring demanding treatment, we serve the whole of Finland.

Our premises are designed for clinical vaccine research; blood samples may be taken and processed as appropriate. At the moment, all but phase I studies can be conducted at our center. Several channels are commonly used for recruiting the research subjects, and among those channels we can select those which best serve each research plan. If necessary, our business enterprises and support services, such as HUS Pharmacy and HUSLAB, are also at your disposal. Clinical Research Institute HUCH is responsible for contracts and finances.  

Read more about our ongoing, upcoming, and completed vaccine studies.